Another ADHD Drug Risk Warning
Stocks for pharm company Cephalon dropped yesterday on news that the FDA may require suicide risk warning on the company's experimental ADHD drug Sparlon. Boo-hoo. An FDA panel is to consider warnings on a suite of ADHD drugs on March 22, although it is unclear whether those warnings will be fore heart problems or suicide or what.
Posted by Philip Dawdy at March 16, 2006 12:02 AM
del.icio.us
Digg it
reddit
